University of Konstanz

Parkinson's & Movement disorders

Parkinson's disease: When molecular guardians need to be protected

Parkinson's disease is the second most common, age-related, neurodegenerative disease: In Germany alone, about 300,000 people are affected and experience sometimes major limitations to their quality of life. Although Parkinson's ...

Vaccination

A general influenza vaccine

New vaccination method for lasting protection against all known influenza mutations in preclinical testing phase—potentially effective also against SARS-CoV-2—joint research project of the University of Konstanz, University ...

Medical research

Acute stress may slow down the spread of fears

New psychology research from the University of Konstanz reveals that stress changes the way we deal with risky information—results that shed light on how stressful events, such as a global crisis, can influence how information ...

Medical research

Alzheimer's and an unusual molecular chaperone

Among the hallmarks of Alzheimer's disease are the Alzheimer fibrils, deposits of the tau protein, which accumulate in nerve cells in the form of fibres and disrupt communication between nerve cells. But how does this fibre ...

Health

Brain measurements reveal success of public health campaigns

By studying how our brains "synchronize" during shared experiences, Konstanz researchers are shedding light on what makes public health campaigns effective—and in the process paving the way to revealing the neural underpinnings ...

Medical research

The positive and negative role of LRH-1 during inflammation

The research group around Professor Thomas Brunner at the University of Konstanz discovers the role that the LRH-1 protein plays in the immune system—Inhibiting this protein could help treat inflammatory diseases

page 2 from 3